What is Semaglutide?
Semaglutide is a GLP-1 receptor agonist that is FDA-approved for type 2 diabetes and for chronic weight management. It works by mimicking an incretin hormone that regulates appetite and blood sugar.
Also known as: GLP-1 receptor agonist
How Semaglutide is studied
Semaglutide is a GLP-1 receptor agonist that mimics an incretin hormone released after eating. It slows gastric emptying, increases satiety, and improves insulin response — mechanisms that underpin its FDA-approved use in type 2 diabetes and chronic weight management.
Commonly researched for
Research status
Important considerations
Prescription medication with known side effects. Use only under medical supervision.
Semaglutide — frequently asked questions
It is FDA-approved for type 2 diabetes and for chronic weight management, backed by large-scale human clinical trials.
Primarily by reducing appetite and slowing stomach emptying, which lowers calorie intake, alongside effects on blood-sugar regulation.
It is an approved prescription medication with a known side-effect profile (commonly gastrointestinal). Use only under medical supervision.